BPG is committed to discovery and dissemination of knowledge
Review
Copyright: ©Author(s) 2026.
Artif Intell Gastroenterol. Nov 8, 2026; 7(3): 125000
Published online Nov 8, 2026. doi: 10.35712/aig.125000
Figure 4
Figure 4 Key studied and emerging applications of artificial intelligence in pancreatic, biliary, and liver diseases: A conceptual summary. Bold and italic text indicates artificial intelligence applications supported by the strongest available clinical evidence. MASLD: Metabolic dysfunction-associated steatotic liver disease; MASH: Metabolic dysfunction-associated steatohepatitis; HCC: Hepatocellular carcinoma; ERCP: Endoscopic retrograde cholangiopancreatography; EHR: Electronic health record; PDAC: Pancreatic ductal adenocarcinoma.


Write to the Help Desk